跳至主要内容
临床试验/CTRI/2023/11/059609
CTRI/2023/11/059609尚未招募3 期

Metabolic Resuscitation in Pediatric Septic Shock Using HAT (Hydrocortisone, Ascorbic acid and Thiamine) Therapy an Open Label Randomized Controlled Trial

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Illness -Admitted to PICU treated for septic shock (fluid refractory shock)
  • Treatment Received inotropes for at least 2 h
  • Consent Parental/caregiver consent prior to or after enrolment
  • (Definitions of surviving sepsis campaign 2020 will be followed for diagnosis of septic shock)

排除标准

  • 1.Age Preterm babies born <34 weeks gestation that have a corrected age of <28 days
  • 2.Treatment - Received inotropes for >24 h pre-enrolment
  • 3.Patient is receiving treatment for a systemic fungal infection or has documented strongyloides infection at the time of randomization
  • 4.Patient undergoing active chemotherapy for cancer treatment
  • 5.Co-morbidities •Fulmonant Myocarditis, Congenital heart disease
  • 6.Chronic hypertension due to cardiovascular or renal disease, requiring regular antihypertensive treatment.
  • 7.Known chronic kidney disease (defined as requiring Renal Replacement Therapy)
  • 8.Known chronic hepatic failure
  • 9.Known diseases affecting the steroid axis, including pituitary disease, congenital adrenal hypoplasia, Cushing or Addison’s
  • 10.Known glucose-6 phosphate dehydrogenase (G-6PD) deficiency
  • 11.Patients with a known history of oxalate nephropathy
  • 12.Patients with acute beriberi disease
  • 13.Patients with acute Wernike’s encephalopathy
  • 14.Patients with known malaria
  • 15.Patients with known suspected scurvy
  • 16.Palliative care patient/patient with limitation of treatment (not for inotropes, cardiopulmonary resuscitation, extracorporeal membrane oxygenation, intubation, or ventilation)
  • 17.Cardiopulmonary arrest in the past 2 h requiring cardiopulmonary resuscitation of >2min duration, or death is deemed to be imminent or inevitable during this admission.
  • 18.Major bleeding with hemorrhagic shock
  • 19.Sepsis is not likely to be the cause of shock

研究者

相似试验